We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
-12.94%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.4M
AUM Growth
-$16.5M
Cap. Flow
+$7.64M
Cap. Flow %
8.64%
Top 10 Hldgs %
95.54%
Holding
14
New
–
Increased
4
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$4.8M
2
TGTX icon
TG Therapeutics
TGTX
+$3.57M
3
SWTX
SpringWorks Therapeutics
SWTX
+$2.57M
4
STOK icon
Stoke Therapeutics
STOK
+$451K

Top Sells

Rank Stock Value
1
ARWR icon
Arrowhead Research
ARWR
+$2.41M
2
BBIO icon
BridgeBio Pharma
BBIO
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.12B
$30.1M 34.03%
6,950,000
+1,046,595
+18% +$4.8M
RCKT icon
2
Rocket Pharmaceuticals
RCKT
$348M
$12.4M 13.99%
722,080
– –
IVVD icon
3
Invivyd
IVVD
$180M
$11.1M 12.55%
9,248,250
– –
TGTX icon
4
TG Therapeutics
TGTX
$8.58B
$5.11M 5.77%
339,500
+235,100
+225% +$3.57M
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
$5.09M 5.75%
197,700
+87,800
+80% +$2.57M
BBIO icon
6
BridgeBio Pharma
BBIO
$16.5B
$5.05M 5.71%
304,700
-114,300
-27% -$1.33M
IONS icon
7
Ionis Pharmaceuticals
IONS
$9.35B
$4.51M 5.1%
126,300
– –
STOK icon
8
Stoke Therapeutics
STOK
$1.82B
$4.44M 5.02%
532,890
+50,000
+10% +$451K
PRQR icon
9
ProQR Therapeutics
PRQR
$243M
$4.07M 4.6%
1,910,600
– –
CRIS icon
10
Curis
CRIS
$9.53M
$2.67M 3.02%
11,205
– –
ARWR icon
11
Arrowhead Research
ARWR
$12.1B
$1.71M 1.94%
67,400
-76,500
-53% -$2.41M
ATRA icon
12
Atara Biotherapeutics
ATRA
$71.2M
$1.27M 1.44%
17,572
– –
SLN
13
Silence Therapeutics
SLN
$521M
$905K 1.02%
145,900
– –
NEXI
14
DELISTED
NexImmune, Inc. Common Stock
NEXI
$50.7K 0.06%
5,338
– –

Similar funds

NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return
WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
MML
Mercato Management Legacy Cottonwood Heights, Utah $54.3M AUM
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53.2M AUM 13.56% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return

M28 Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, M28 Capital Management held 14 positions worth $88.4M, down 16% from $105M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

M28 Capital Management deployed $7.64M of net new capital in Q1 2023, adding to 4 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Arrowhead Research, an estimated $2.41M trimmed.

  • M28 Capital Management added most to Wave Life Sciences in Q1 2023, an estimated $4.8M increase.
  • M28 Capital Management's biggest Q1 2023 reduction was Arrowhead Research, cutting an estimated $2.41M.
  • M28 Capital Management's ten largest holdings make up 96% of its $88.4M portfolio in Q1 2023.
  • M28 Capital Management opened 0 new positions and closed 0 in Q1 2023.
  • M28 Capital Management's portfolio value fell 16% quarter-over-quarter to $88.4M.

Based on M28 Capital Management's 13F filing for Q1 2023, filed 12 May 2023.